Citadel Advisors’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELGX
ACH
CCM
BCM
NMC
SI
PCM
EWM
Citadel Advisors's ELGX Position: Q1 2019 in Review
Citadel Advisors sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 85,148 shares — an estimated $610K sold.
Citadel Advisors first reported a position in ELGX in Q2 2013 and held it in 18 quarters. The position peaked at $15.1M in Q3 2014. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.
- Citadel Advisors reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
- Citadel Advisors sold 85,148 Endologix Inc shares in Q1 2019, an estimated $610K.
- Citadel Advisors first reported a position in Endologix Inc in Q2 2013 and held it in 18 quarters.
- Citadel Advisors's Endologix Inc position peaked at $15.1M in Q3 2014.
- 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.